Applying quantitative structure-activity relationship (QSAR) methodology for modeling postmortem redistribution of benzodiazepines and tricyclic antidepressants.

Postmortem redistribution (PMR) constitutes a multifaceted process, which complicates the interpretation of drug concentrations by forensic toxicologists. The present study aimed to apply quantitative structure-activity relationship (QSAR) analysis for modeling PMR data of structurally related drugs, 10 benzodiazepines and 10 tricyclic antidepressants. For benzodiazepines, an adequate QSAR model was obtained (R(2) = 0.98, Q(2) = 0.88, RMSEE = 0.12), in which energy, ionization and molecular size exerted significant impact. For tricyclic antidepressants, an adequate QSAR model with slightly inferior statistics (R(2) = 0.95, Q(2) = 0.87, RMSEE = 0.29) was established after exclusion of maprotiline, in which energy parameters, basicity character and lipophilicity exerted significant contribution. Thus, QSAR analysis could be used as a complementary tool to provide an informative illustration of the contributing molecular, physicochemical and structural properties in PMR process. However, the complexity, non-static and time-dependent nature of PMR endpoints raises serious concerns whether QSAR methodology could predict the degree of redistribution, highlighting the need for animal-derived PMR data.

[1]  Fumiyoshi Yamashita,et al.  In silico approaches for predicting ADME properties of drugs. , 2004, Drug metabolism and pharmacokinetics.

[2]  O. Drummer,et al.  Postmortem Drug Analysis: Analytical and Toxicological Aspects , 2002, Therapeutic drug monitoring.

[3]  Ronald Eugene Shaffer,et al.  Multi‐ and Megavariate Data Analysis. Principles and Applications, I. Eriksson, E. Johansson, N. Kettaneh‐Wold and S. Wold, Umetrics Academy, Umeå, 2001, ISBN 91‐973730‐1‐X, 533pp. , 2002 .

[4]  H. Bonnell,et al.  Postmortem Drug Redistribution. , 2001, Forensic science review.

[5]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.

[6]  F. Moriya,et al.  Redistribution of basic drugs into cardiac blood from surrounding tissues during early-stages postmortem. , 1999, Journal of forensic sciences.

[7]  R A Braithwaite,et al.  Estimating antemortem drug concentrations from postmortem blood samples: the influence of postmortem redistribution , 2000, Journal of clinical pathology.

[8]  E. Spina,et al.  Metabolic drug interactions with newer antipsychotics: a comparative review. , 2007, Basic & clinical pharmacology & toxicology.

[9]  R. Ferner,et al.  Post-mortem clinical pharmacology. , 2008, British journal of clinical pharmacology.

[10]  Ivonne M C M Rietjens,et al.  Promises and pitfalls of quantitative structure-activity relationship approaches for predicting metabolism and toxicity. , 2008, Chemical research in toxicology.

[11]  A. Tsantili-Kakoulidou,et al.  Application of quantitative structure–activity relationships for modeling drug and chemical transport across the human placenta barrier: a multivariate data analysis approach , 2009, Journal of applied toxicology : JAT.

[12]  William A Watson,et al.  Post-mortem Toxicology: What The Dead Can And Cannot Tell Us , 2003, Journal of toxicology. Clinical toxicology.

[13]  B. Logan,et al.  Lack of predictable site-dependent differences and time-dependent changes in postmortem concentrations of cocaine, benzoylecgonine, and cocaethylene in humans. , 1997, Journal of analytical toxicology.

[14]  M. L. Ribeiro,et al.  Quantitative method for the determination of organochlorine pesticides in serum. , 1996, Journal of analytical toxicology.

[15]  C. L. Winek,et al.  Drug and chemical blood-level data 2001. , 2001, Forensic science international.

[16]  J. Mørland,et al.  Postmortem drug redistribution--human cases related to results in experimental animals. , 1999, Journal of forensic sciences.

[17]  R. Flanagan,et al.  Interpretation of Analytical Toxicology Results in Life and at Postmortem , 2005, Toxicological reviews.

[18]  A. Tsantili-Kakoulidou,et al.  Quantitative structure-activity relationship (QSAR) methodology in forensic toxicology: modeling postmortem redistribution of structurally diverse drugs using multivariate statistics. , 2009, Forensic science international.

[19]  W. H. Anderson,et al.  The forensic science implications of site and temporal influences on postmortem blood-drug concentrations. , 1990, Journal of forensic sciences.

[20]  Timothy J Carlson,et al.  Recent advances in high throughput screening for ADME properties. , 2008, Combinatorial chemistry & high throughput screening.

[21]  Thomas Steger-Hartmann,et al.  Use of computer-assisted prediction of toxic effects of chemical substances. , 2006, Toxicology.

[22]  D. Garbutt,et al.  A Comparison of Drug Concentrations in Postmortem Cardiac and Peripheral Blood in 320 Cases , 1995 .

[23]  A. Vedani,et al.  In silico prediction of harmful effects triggered by drugs and chemicals. , 2005, Toxicology and applied pharmacology.

[24]  R. F. Shaw,et al.  Concentrations of basic drugs in postmortem human myocardium. , 1982, Journal of toxicology. Clinical toxicology.

[25]  E. Vuori,et al.  Newer antidepressants: evaluation of fatal toxicity index and interaction with alcohol based on Finnish postmortem data , 2005, International Journal of Legal Medicine.

[26]  C. E. Becker,et al.  Key Concepts in Postmortem Drug Redistribution , 2005, Clinical toxicology.

[27]  P. Marquet,et al.  Mechanisms underlying postmortem redistribution of drugs: a review. , 2003, Journal of analytical toxicology.

[28]  Maria Sandberg,et al.  Multivariate Design and Modelling in QSAR, Combinatorial Chemistry, and Bioinformatics , 2000 .

[29]  Kabrena E. Rodda,et al.  The redistribution of selected psychiatric drugs in post-mortem cases. , 2006, Forensic science international.

[30]  Robert A. Anderson,et al.  Comparison of molecularly imprinted solid-phase extraction (MISPE) with classical solid-phase extraction (SPE) for the detection of benzodiazepines in post-mortem hair samples. , 2008, Forensic science international.

[31]  Alexander Golbraikh,et al.  Predictive QSAR modeling workflow, model applicability domains, and virtual screening. , 2007, Current pharmaceutical design.

[32]  P. Marquet,et al.  Post-mortem redistribution of three beta-blockers in the rabbit , 2006, International Journal of Legal Medicine.

[33]  G. Jones,et al.  Post-mortem drug redistribution--a toxicological nightmare. , 1990, Forensic science international.

[34]  O. Drummer Post-mortem toxicology. , 2007, Forensic science international.